LOS ANGELES, CA / ACCESSWIRE / September 25, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Bank OZK ("Bank OZK" or "the Company") (NASDAQ:OZK) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or […]
LOS ANGELES, CA / ACCESSWIRE / September 25, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in WideOpenWest, Inc. ("WideOpenWest" or "the Company") (NYSE:WOW) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses
LOS ANGELES, CA / ACCESSWIRE / September 25, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ZoomInfo Technologies Inc. ("ZoomInfo" or "the Company") (NASDAQ:ZI) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by
LOS ANGELES, CA / ACCESSWIRE / September 25, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against WEBTOON Entertainment Inc. ("Webtoon" or "the Company") (NASDAQ:WBTN) for violations of the federal securities laws. Investors who purchased the Company’s securities pursuant and/or traceable to the
LOS ANGELES, CA / ACCESSWIRE / September 25, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Warner Bros. Discovery, Inc. ("Warner Bros. Discovery" or "the Company") (NASDAQ:WBD) for violations of the securities laws. The investigation focuses on whether the Company
LOS ANGELES, CA / ACCESSWIRE / September 25, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Actinium Pharmaceuticals, Inc. ("Actinium" or "the Company") (NYSE American:ATNM) for violations of the securities laws. The investigation focuses on whether the Company issued false
LOS ANGELES, CA / ACCESSWIRE / September 25, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Lions Gate Entertainment Corp. ("Lions Gate" or "the Company") (NYSE:LGF-A)(NYSE:LGF-B) for violations of the securities laws. The investigation focuses on whether the Company issued
LOS ANGELES, CA / ACCESSWIRE / September 25, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Enfusion, Inc. ("Enfusion" or "the Company") (NYSE:ENFN) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading
LOS ANGELES, CA / ACCESSWIRE / September 25, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Ibotta, Inc. ("Ibotta" or "the Company") (NYSE:IBTA) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading
LOS ANGELES, CA / ACCESSWIRE / September 25, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Syros Pharmaceuticals, Inc. ("Syros" or "the Company") (NASDAQ:SYRS) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or